![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 45, 31751-31754, November 5, 1999
From the Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710
Mucins are major glycoprotein components
of the mucous that coats the surfaces of cells lining the respiratory,
digestive, and urogenital tracts, and in some amphibia, the skin. They
function to protect epithelial cells from infection, dehydration, and
physical or chemical injury, as well as to aid the passage of materials through a tract. Individual organisms make several structurally different mucins, and a given mucin may be found in more than one organ
(see Supplemental Material). Members of the mucin family can differ
considerably in size. Some are small, containing a few hundred amino
acid residues, whereas others contain several thousands of residues and
are among the largest known proteins. Irrespective of size, all mucin
polypeptide chains have domains rich in threonine and/or serine whose
hydroxyl groups are in O-glycosidic linkage with
oligosaccharides. Moreover, these domains are composed of tandemly
repeated sequences that vary in number, length, and amino acid sequence
from one mucin to another (1). The carbohydrate content of a mucin may
account for up to 90% of its weight. There are two types of mucins,
membrane-bound and secreted. Of the human mucins, two are
membrane-bound (MUC1 and MUC4) (2, 3) and four are secreted (MUC2,
MUC5AC, MUC5B, and MUC7) (4-7). The three other mucins (MUC3, MUC6,
and MUC8) (8-11) cannot be classified. Each human mucin has a
counterpart in other animals. Thus, porcine submaxillary mucin
(PSM)1 (12), one of the most
thoroughly characterized mucins, has a tissue distribution and
structure similar to MUC5B. An increasing number of proteins that are
not mucins also contain highly O-glycosylated domains called
"mucin-like domains."
The functions of mucins are dependent on their ability to form viscous
solutions or gels. Although the highly glycosylated domains of mucins
are devoid of secondary structures, they are long extended structures
that are much less flexible than unglycosylated random coils. The
oligosaccharides contribute to this stiffness in two ways, by limiting
the rotation around peptide bonds and by charge repulsion among the
neighboring, negatively charged oligosaccharide groups (13). Such long,
extended molecules have a much greater solution volume than native or
denatured proteins with little or no carbohydrate and endow aqueous
mucin solutions with a high viscosity. Mucins protect against infection
by microorganisms that bind cell surface carbohydrates, and mucin genes
appear to be up-regulated by substances derived from bacteria,
e.g. lipopolysaccharides (14).
This review will summarize what is known about the polypeptide
structures of the secreted mucins and how some, in particular PSM, are
assembled via interchain disulfide bonds into molecules with molecular
weights in the millions. We will not consider membrane-bound mucins,
which were the subject of earlier reviews (1, 15, 16).
Complete amino acid sequences have been described for frog
(Xenopus) integumentary mucins FIM-A.1 (17) and FIM-B.1
(18), PSM (12), RSM (19), MSM (20), MUC2 (4), MUC5B (6), and MUC7 (7)
and almost complete sequences for MUC5AC (5) and rat Muc2 (21). The
different domains of mucins are shown in Fig.
1. Many of the domains show sequence
identities and possibly similar functions in different mucins. These
mucins vary greatly in size, from as few as 322 residues to 13,288 residues. The sequences of mucin polypeptides were deduced almost
completely by recombinant DNA methods, and the physical-chemical
properties of some mucins have not been determined. Nevertheless, it is
well established that the oligosaccharides in many secreted mucins,
e.g. PSM (22), show structural microheterogeneity, with
GalNAc
![]()
INTRODUCTION
TOP
INTRODUCTION
General Structural Features
Assembly of Mucin Multimers
Concluding Remarks
REFERENCES
![]()
General Structural Features
TOP
INTRODUCTION
General Structural Features
Assembly of Mucin Multimers
Concluding Remarks
REFERENCES
-O-Ser/Thr as the sugar-protein linkage upon which
other sugars are added. Most mucins have negatively charged sugars,
either sialic acid or O-sulfosaccharides.

View larger version (26K):
[in a new window]
Fig. 1.
A, comparison of the domains in the
polypeptide chains of four secreted mucins with the corresponding
domains in human von Willebrand factor. B, the domain
structures of two small secreted mucins not related to human von
Willebrand factor. The complete amino acid sequence of each polypeptide
has been established. The number in parenthesis is the number of amino
acid residues in the polypeptide. The length of each polypeptide in
A is proportional to the number of amino acid residues it
contains. The polypeptide chain lengths in A and
B are not drawn to the same scale.
Tandem Repeat Domains-- The number, length, and amino acid sequence of the repeats vary among different mucins, as shown in the Supplemental Material. The tandem repeat domains are flanked on either side by other types of domains (Fig. 1). All of the serine and threonine residues in the repeat domain of PSM have O-linked oligosaccharides (23), but this is not known for other mucins. The repeats in some mucins have identical sequences, whereas in others the repeat sequence is degenerate. The lack of secondary structures in the repeat domains and their flanking domains suggests that these domains serve as a scaffold for O-linked oligosaccharides (24), whose properties determine in large part the properties of a mucin. Light scattering and electron microscopy suggest that these glycosylated domains are semi-rigid, extended structures (13, 25). The tandem repeat domains in many mucins, e.g. PSM (12) and MUC5B (6), are encoded by a single large exon, although the remainder of the mucin is encoded by short exons separated by long introns. Many mucins show length polymorphism as the result of multiple alleles that encode different numbers of tandem repeats (26). Thus, PSM is encoded by at least three alleles with 99, 110, and 135 repeats, respectively (12).
The Amino-terminal Disulfide-rich D-domains-- Several disulfide-rich domains are found in secreted mucins except RSM (19), MSM (20), and MUC7 (7) and are often at either end of the polypeptide (Fig. 1). The disulfide-rich D-domain in mucins first found in VWF (27) is now recognized in many other proteins (28-31). Many secreted mucins contain three NH2-terminal D-domains, designated D1, D2, and D3, and some a fourth domain, D4, at the COOH terminus (Fig. 1). A partial D-domain, D', is between D2 and D3 in all secreted mucins and VWF. Each domain, which contains up to 30 1/2Cys, shows significant sequence identity with the other D-domains, especially the half-cystines. Comparisons of the sequences of the D-domains and other 1/2Cys-rich domains are given as supplemental information (see Supplemental Material). The D1-, D2-, and D3-domains of PSM are N-glycosylated when expressed in COS-7 cells (32), but this is not known for other mucins. In PSM and VWF all of the 1/2Cys in the D1-, D2-, D3-, and CK-domains are thought to form disulfide bonds, some of which are intrachain bonds whereas others are interchain bonds that are involved in assembly of PSM and VWF into multimers (see below).
The COOH-terminal Disulfide-rich/CK-domains--
A
240-325-residue domain with 29-33 1/2Cys is at the COOH
terminus of many mucins (4-6, 12, 18, 33, 34) (see Supplemental Material) (Fig. 1). These mucin domains have significant sequence identity with one another and with those at the carboxyl terminus of
other proteins (27, 28, 30). Like the D-domains, they are predicted to
have globular structures with
-helices and pleated sheets and few or
no free thiols (35). They very likely contain N-linked
oligosaccharides at one or more acceptor motifs (NX(S/T)) (36). The first 100-130 residues in this domain have sequence identity
with the C-domains of VWF, but the last 90-120 residues from the COOH
terminus have sequence identities with the CK-domain at the COOH
terminus of VWF (27). The CK-domains are homologous to the "cystine
knot" superfamily of proteins that includes transforming growth
factor
2, nerve growth factor, platelet-derived growth factor, and
chorionic gonadotropin (37). The CK-domains of VWF and mucins show
significant sequence identity to norrin, a 133-residue protein that in
mutant form gives rise to Norrie disease in humans, a rare, sex-linked
disorder characterized by congenital blindness, mental retardation, and
deafness (38). The CK-domain provides the 1/2Cys that form
interchain disulfide bonds between the polypeptide chains of VWF and
PSM and presumably other mucins (27, 35, 36, 39) (see below).
Other Mucin Domains--
A B-domain with sequence identity to
those in VWF (27) is found in several mucins (4-6, 21) (Fig. 1).
Half-cystine-rich domains other than the D- and CK-domains are noted in
a few mucins (Fig. 1), and P-domains like those in the trefoil factor
family (40, 41) (see Supplemental Material) are in some frog mucins. Epidermal growth factor-like domains are found in other mucins (8, 42,
43).
| |
Assembly of Mucin Multimers |
|---|
|
|
|---|
It is well known that the molecular weight of many mucins
decreases in the presence of reducing agents (e.g. Ref. 44),
suggesting that interchain disulfide bonds maintain mucins in a
multimeric state. Studies on the biosynthesis of mucins in tissue
explants (45) and cells in culture (46-50) have confirmed the role of disulfide bonds in the assembly of mucins into multimers. The recognition that mucins had disulfide-rich domains structurally similar
to those in VWF and the fact that VWF formed disulfide-bonded multimers
through its disulfide-rich domains (27) indicated a possible role of
these domains in mucin multimer formation. However, the large size of
mucin polypeptides and their high carbohydrate content prevented use of
the conventional methods of protein chemistry for examining the
molecular details of mucin multimer formation. Fortunately it has been
possible to obtain insights into multimer formation by expression of
plasmids encoding mucin domains in mammalian cells followed by
characterization of the recombinant proteins by SDS-gel electrophoresis
and chromatography under reducing and non-reducing conditions. This
approach has been particularly successful for examining multimer
formation in PSM (32, 35, 36, 51), with the assumption that the
assembly of domains accurately reflects the assembly of native mucins
in vivo. Thus, as illustrated in Fig.
2, PSM is thought to form
disulfide-linked dimers through its COOH-terminal CK-domains, and the
dimers then form disulfide-bonded multimers through their
NH2-terminal D-domains. It is likely that all mucins
structurally related to VWF (Fig. 1), in addition to rat Muc2, MUC5AC,
BSM, CTM, PGM, and MUC6, form multimers similar to those formed by
PSM.
|
Dimerization through the CK-domains-- Two polypeptide chains of PSM form disulfide-linked dimers through their CK-domains soon after their biosynthesis in the endoplasmic reticulum (35, 36). Pulse-chase studies show that dimerization is very rapid and occurs concomitant with or soon after N-glycosylation. N-Glycosylation is not required for dimer formation or later during multimer formation because both processes are unaffected by tunicamycin (32, 35, 36). However, unglycosylated species are poorly secreted and/or rapidly degraded after secretion into the extracellular medium (32). The fact that brefeldin A, a compound that disrupts the Golgi complex, has no effect on dimer formation and that dimers are formed before N-linked oligosaccharides become endoglycosidase H-resistant indicates that dimerization is confined to the endoplasmic reticulum. Subsequent to the studies on the dimerization of PSM, rat Muc2 was also reported to form disulfide-linked dimers through its COOH-terminal disulfide-rich domain, which includes the CK-domain (39) (see Supplemental Material). Dimer formation by other types of mucins has not been examined by expression of plasmids encoding the CK-domains. However, mucins secreted by mucin-producing cells in culture (47-50), including MUC2, MUC5AC, and likely MUC5B and MUC6, appear to form disulfide-linked dimers shortly after their synthesis in the endoplasmic reticulum. In contrast to PSM, N-glycosylation is reported to be required for dimerization of rat Muc2, MUC2, and MUC5AC.
The interchain disulfide bonds in PSM dimers have been examined by
site-directed mutagenesis (35). Of the 11 1/2Cys in the CK-domain, mutation of 8 is without effect on dimer formation. Dimerization is partly impaired by mutation of 3 1/2Cys at
residues 13223, 13244, and 13246. C13244 and
C13246 are in the sequence
C13244LC13246C, which is conserved in all
mucins and other proteins containing the CK-domain (Fig.
3) (see Supplemental Material) and is
also critical for interchain disulfide bond formation in VWF (27) and
norrin (53). C13223 in PSM in the sequence
C13223VGEC is also required for efficient dimer formation,
but the mutant proteins at this residue are poorly secreted (35),
suggesting that this sequence motif may be important in folding of the
CK-domain in the endoplasmic reticulum. This sequence motif is also
conserved in all mucins, VWF, and norrin (Fig. 3) (see Supplemental
Material), which attests to its importance in maintaining the structure
of the CK-domain.
|
O-Glycosylation of the Repeat Domain-- The incorporation of O-linked oligosaccharides into mucins begins after N-glycosylation and disulfide-linked dimer formation as suggested by biosynthetic studies on MUC2 (49) and MUC5AC (50) and cytochemical studies of PSM (54, 55). O-Glycosylation of PSM begins when the dimers reach the cis-Golgi compartments, because the GalNAc transferase that forms the GalNAc-Ser/Thr linkages and the mucin precursors bearing only GalNAc have been located by electron microscopy in the cis-Golgi in mucous cells of submaxillary glands (54, 55). Moreover, unglycosylated mucin precursors are detected only in the lumen of the endoplasmic reticulum (55). Other cells expressing secreted mucins, including intestinal goblet cells (56), also appear to initiate O-glycosylation in the cis-Golgi although in certain mucin-producing cell lines O-glycosylation is found to begin in the endoplasmic reticulum (46, 57). The completion of the biosynthesis of the O-linked oligosaccharides in secreted mucins continues in the medial- and trans-Golgi compartments where the requisite glycosyltransferases for elongation and termination of the oligosaccharides are located (58).
Multimerization through the D-Domains-- Expression in COS-7 cells of plasmids encoding the three D-domains of PSM has shown that these domains participate in formation of interchain disulfide bonds between disulfide-linked dimers to give very high molecular weight multimers of mucin (32). Multimer formation differs from dimer formation in several respects. Brefeldin A, which disrupts the Golgi complex, inhibits multimer formation, indicating that multimers form in the Golgi complex. Compounds that increase the pH of the trans-Golgi compartments, such as chloroquine and monensin, also inhibit multimer formation but not dimerization (32). Bafilomycin, a specific inhibitor of the vacuolar H+-ATPase that maintains the trans-Golgi compartments at a slightly acidic pH, also inhibits multimer formation. These observations suggest that the interchain disulfide bonds that give rise to multimers are formed at a slightly acidic pH in the trans-Golgi complex through 1/2Cys residues in the D-domains. The molecular weights of the multimers cannot be assessed accurately by SDS-gel electrophoresis because they are so large they do not enter the running gel under non-reducing conditions. However, species with a size of trimers were observed when the three D-domains were expressed together (32), suggesting that a step in the process of multimerization is trimer formation of disulfide-linked dimers. Such multimers are likely branched structures as indicated in Fig. 2. Recombinant PSM containing no glycosylated domains is secreted from COS-7 cells as dimers and multimers and indicates that like VWF not all dimers are converted to multimers (32). C1199 in the D3-domain of PSM has been found by site-directed mutagenesis studies to be a likely candidate for forming one of the interchain disulfide bonds in mucin multimers (51). It is in the sequence C1199SWRYEPCG, which is highly conserved in secreted mucins (Fig. 3) (see Supplemental Material), and the analogous 1/2Cys in VWF is required for its multimerization (27). In contrast, C1276, which is suggested to form interchain disulfide bonds in VWF (27), does not form such bonds in PSM (51). The other half-cystines in the D-domains that form interchain disulfide bonds are not known.
VWF multimers are formed from prepro-VWF, which is cleaved intracellularly by a subtilisin-like protease (furin) at R763 in the sequence motif R760SKR763 in the D'-domain (27). The released propeptide contains the D1- and D2-domains and is essential for multimer formation although cleavage is not. Cleavage may not be essential for mucin multimerization because the D'-domains of mucins do not contain the sequence motif required for proteolytic cleavage of prepro-VWF. The observation that the D-domains of PSM are not cleaved when expressed in COS-7 or MOP-8 cells (32) is consistent with the lack of the cleavage motif in the D'-domain of PSM (see Supplemental Material). However, some proteolytic processing of mucins is possible as suggested by recent studies showing that cleavage occurs in the COOH-terminal region of MUC2 (59), MUC5B (60), and rat Muc2 (61), although a role for such cleavages in mucin assembly is unknown. Moreover, proteolytic cleavage during purification of the mucins was not ruled out.
The prediction that PSM contains branched multimers indicates that branches should be observed on electron microscopy of mucins. It is generally argued that mucins form linear polymers (e.g. see Ref. 45), which has been substantiated by electron microscopy (24). Moreover, VWF forms dimers through its CK-domains, and the dimers form linear multimers through their D-domains (27). It is quite possible that some mucins with disulfide-rich domains do not form multimers in the manner proposed for PSM. However, mucins are highly susceptible to proteolysis during isolation (62, 63), and further electron microscopic studies should be made on well characterized preparations. Of interest is a recent report describing branched structures for MUC5B in respiratory secretions of asthmatic individuals (64). Nevertheless, additional mechanisms of mucin assembly are supported by studies on MUC2. LS174T cells synthesize soluble MUC2 disulfide-linked dimers, but higher molecular weight species are water-insoluble (65). Apparently, the water-insoluble species are assembled in the Golgi complex following initial O-glycosylation by a pH-independent process. These insoluble complexes are partly maintained by non-reducible chemical bonds of unknown nature (65). It is not known whether the complexes are secreted, although MUC2 in the intestine is thought to be part of an insoluble glycoprotein complex (59). Other studies suggest that MUC2 is assembled into large soluble, disulfide-linked oligomers/multimers (47, 66). Clearly, MUC5AC (67) and MUC5B (60) are large soluble, gel-forming mucins stabilized by disulfide bonds.
As described above, the assembly of PSM and VWF (27) involves
dimerization in the endoplasmic reticulum and multimerization in the
trans-Golgi compartments. The molecular mechanisms that permit this
compartmentalization are not known, but the NH2-terminal D-domains and the CGLCG motifs in the D1- and D3-domains seem to play
critical roles (51). Plasmids encoding only the D1- and D2-domains, the
D1- and the D3-domains, or the D3-domain of PSM expressed mucin
oligomers in the presence of monensin suggesting that the three domains
must be contiguous to avoid multimerization at the non-acidic pH of the
endoplasmic reticulum and the cis- and
medial-Golgi compartments. Replacement of the two
1/2Cys by alanine in the CGLCG motif in the D3-domain permits
formation of multimers in the presence of monensin (51). Thus, the
motif in the D3-domain prevents multimerization of mucin in the
non-acidic compartments of the endoplasmic reticulum and the
cis/medial-Golgi compartments. Replacement of the two
1/2Cys by alanine in the CGLCG motif in the D1-domain
dramatically reduces the rate of formation of disulfide-linked
multimers (51). This observation suggests that multimerization at low
pH in the acidic trans-Golgi compartments requires the motif
in the D1-domain. Multimerization of VWF also requires the CGLCG motif
in the D1-domain (27), although a role for the motif in the D3-domain
has not been reported. VWF has another CGLCG motif in the D2-domain
that is also required for its assembly (27). However, among the mucins
structurally related to VWF, only MUC5AC and MUC5B have CGLCG motifs in
their D2-domains (see Supplemental Material). The exact roles of the
CGLCG motifs remain unknown but because of the fact that similar motifs
are in the active sites of proteins involved in catalyzing formation of
disulfide bonds during protein folding, such as protein disulfide isomerase (Fig. 3), the question arises whether these motifs have a
direct role in formation of disulfide bonds in mucins.
| |
Concluding Remarks |
|---|
|
|
|---|
Much progress has been made recently in our understanding of the
structure and assembly of secretory mucins, but much work remains for
the future. Other members of the mucin family should be identified and
their structures and mechanism of assembly into disulfide-bonded
multimers elucidated. The pairing of half-cystines to form the many
disulfide bonds in the globular domains must be established, and the
role of chaperones in folding of these domains must also be determined.
The molecular basis for the regulated/polarized transport of mucins
should be explored. These kinds of studies will be needed to obtain
further insights into the exact biological roles of mucins.
| |
FOOTNOTES |
|---|
* This minireview will be reprinted in the 1999 Minireview Compendium, which will be available in December, 1999. This work was supported in part by NIGMS Grant 27566 from the National Institutes of Health (to R. L. H.).
The on-line version of this article (available at
http://www.jbc.org) contains supplemental material including
comparisons of amino acid sequences, accession numbers for proteins,
tissue distribution of secreted mucins, and additional references.
To whom correspondence should be addressed: Dept. of Biochemistry,
P. O. Box 3711, Duke University Medical Center, Durham, NC 27710. Tel.: 919-681-8805; Fax: 919-684-5040; E-mail: hill@biochem. duke.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PSM, porcine submaxillary mucin; BSM, bovine submaxillary mucin; CTM, canine tracheobronchial mucin; FIM, frog integumentary mucin; MSM, mouse submandibular mucin; PGM, porcine gastric mucin; RSM, rat submandibular mucin; VWF, human von Willebrand factor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Gendler, S. J., and Spicer, A. P. (1995) Annu. Rev. Physiol. 37, 607-634[CrossRef] |
| 2. |
Gendler, S. J.,
Lancaster, C. A.,
Taylor-Papadimitriu, J.,
Duhig, T.,
Peat, N.,
Burchell, J.,
Pemberton, L.,
Lalani, E. N.,
and Wilson, D.
(1990)
J. Biol. Chem.
265,
15286-15293 |
| 3. | Moniaux, N., Nollet, S., Porchet, N., Degand, P., Laine, A., and Aubert, J.-P. (1999) Biochem. J. 338, 325-333 |
| 4. |
Gum, J. R.,
Hicks, J. W.,
Toribara, N. W.,
Siddiki, B.,
and Kim, Y. S.
(1994)
J. Biol. Chem.
269,
2440-2446 |
| 5. |
Li, D.,
Gallup, M.,
Fan, N.,
Szymkowski, D. E.,
and Basbaum, C. B.
(1998)
J. Biol. Chem.
273,
6812-6820 |
| 6. |
Desseyn, J. L.,
Aubert, J. P.,
van Seuningen, I.,
Porchet, N.,
and Laine, A.
(1997)
J. Biol. Chem.
272,
16873-16883 |
| 7. |
Bobek, L. A.,
Tsa, H.,
Biesbrock, A. R.,
and Levine, M. J.
(1993)
J. Biol. Chem.
268,
20563-20569 |
| 8. | Gum, J. R., Ho, J. J. L., Pratt, W. S., Hicks, J. W., Hill, A. S., Vinall, L. E., Roberton, A. M., Swallow, D. M., and Kim, Y. S. (1992) J. Biol. Chem. 267, 26678-26686 |
| 9. |
Toribara, N. W.,
Ho, S. B.,
Gum, E.,
Gum, J. R.,
Lau, P.,
and Kim, Y. S.
(1997)
J. Biol. Chem.
272,
16398-16403 |
| 10. | Shankar, V., Pichan, P., Eddy, R. L., Jr., Tonk, V., Nowak, N., Sait, S. N., Shows, T. B., Schultz, R. E., Gotway, G., Elkins, R. C., Gilmore, M. S., and Sachdev, G. P. (1997) Am. J. Respir. Cell Mol. Biol. 16, 232-241[Abstract] |
| 11. | Pigny, P., Guyonnet-Duperat, V., Hill, A. S., Pratt, W. S., Galiegue-Zouitina, S., Vinall, L., Collyn D'Hooge, M., Laine, A., Van-Seuningen, I., Degand, P., Gum, J. R., Kim, Y. S., Swallow, D. M., Aubert, J.-P., and Porchet, N. (1996) Genomics 38, 340-352[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Eckhardt, A. E.,
Timpte, C. S.,
DeLuca, A. W.,
and Hill, R. L.
(1997)
J. Biol. Chem.
272,
33204-33210 |
| 13. | Jentoft, N. (1991) Trends Biochem. Sci. 15, 291-294 |
| 14. | Dohrman, A., Miyata, S., Gallup, M., Li, J. D., Chapelin, C., Coste, A., Escudier, E., Nadel, J., and Basbaum, C. (1998) Biochim. Biophys. Acta 1406, 251-259[Medline] [Order article via Infotrieve] |
| 15. | Hilkens, J., Marjolyn, J. L., Ligtenberg, H. L. V., and Litvinov, S. V. (1992) Trends Biochem. Sci. 17, 359-363[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | McNeer, R. R., Huang, D., Fregien, N. L., and Carraway, K. L. (1998) Biochem. J. 330, 737-744 |
| 17. |
Hoffmann, W.
(1988)
J. Biol. Chem.
263,
7686-7690 |
| 18. |
Joba, W.,
and Hoffmann, W.
(1997)
J. Biol. Chem.
272,
1805-1810 |
| 19. |
Albone, E. F.,
Hagen, F. K.,
VanWuyckhuyse, B. C.,
and Tabak, L. A.
(1994)
J. Biol. Chem.
269,
16845-16852 |
| 20. |
Denny, P. C.,
Mirels, L.,
and Denny, P. A.
(1996)
Glycobiology
6,
43-50 |
| 21. |
Ohmori, H.,
Dohrman, A. F.,
Gallup, M.,
Tsuda, T.,
Kai, H.,
Gum, J. R.,
Kim, Y. S.,
and Basbaum, C. B.
(1994)
J. Biol. Chem.
269,
17833-17840 |
| 22. |
Gerken, T. A.,
Owens, C. L.,
and Pasumarthy, M.
(1998)
J. Biol. Chem.
273,
26580-26588 |
| 23. |
Gerken, T. A.,
Owens, C. L.,
and Pasumarthy, M.
(1997)
J. Biol. Chem.
272,
9709-9719 |
| 24. |
Eckhardt, A. E.,
Timpte, C. S.,
Abernethy, J. L.,
Toumadje, A.,
Johnson, W. C., Jr.,
and Hill, R. L.
(1987)
J. Biol. Chem.
262,
11339-11344 |
| 25. | Marianne, T., Perini, J.-M., Lafitte, J.-J., Houdret, N., Pruvot, F.-R., Lamblin, G., Slayter, H. S., and Roussel, P. (1987) Biochem. J. 248, 189-195[Medline] [Order article via Infotrieve] |
| 26. | Vinall, L. E., Hill, A. S., Pigny, P., Pratt, W. S., Toribara, N., Gum, J. R., Kim, Y. S., Porchet, N., Aubert, J.-P., and Swallow, D. M. (1998) Hum. Genet. 102, 357-366[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Sadler, J. E. (1998) Annu. Rev. Biochem. 67, 395-424[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Kotani, E., Yamakawa, M., Iwamoto, S., Tashiro, M., Mori, H., Sumida, M., Matsubara, F., Taniani, K., Kadono-Okuda, K., Kato, Y., and Mori, H. (1995) Biochim. Biophys. Acta 1260, 245-268[Medline] [Order article via Infotrieve] |
| 29. |
Gao, Z.,
and Garbers, D. L.
(1998)
J. Biol. Chem.
273,
3415-3421 |
| 30. |
Cohen-Salmon, M.,
El-Amraqui, A.,
Leibovici, M.,
and Petit, C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14450-14455 |
| 31. |
Legan, P. K.,
Rau, A.,
Keen, J. F.,
and Richardson, G. P.
(1997)
J. Biol. Chem.
272,
8791-8801 |
| 32. |
Perez-Vilar, J.,
Eckhardt, A.,
DeLuca, A. W.,
and Hill, R. L.
(1998)
J. Biol. Chem.
273,
14442-14449 |
| 33. | Jiang, W., Woitach, J. T., Keil, R. L., and Bhavanandan, V. P. (1998) Biochem. J. 331, 193-199 |
| 34. |
Verma, M.,
and Davidson, E. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7144-7148 |
| 35. |
Perez-Vilar, J.,
and Hill, R. L.
(1998)
J. Biol. Chem.
273,
6982-6988 |
| 36. |
Perez-Vilar, J.,
Eckhardt, A. E.,
and Hill, R. L.
(1996)
J. Biol. Chem.
271,
9845-9850 |
| 37. | Sun, P. D., and Davies, D. R. (1995) Annu. Rev. Biophys. Biomol. Struct. 24, 269-291[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Meitinger, T., Meindl, A., Bork, P., Rost, B., Sander, C., Haasemann, M., and Murken, J. (1993) Nat. Genet. 5, 376-380[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Bell, S. L., Khatri, I. A., Xu, G., and Forstner, J. F. (1998) Eur. J. Biochem. 263, 123-131 |
| 40. |
Hauser, F.,
and Hoffman, W.
(1992)
J. Biol. Chem.
267,
24620-24624 |
| 41. | Sands, B. E., and Podolsky, D. K. (1996) Annu. Rev. Physiol. 58, 253-273[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Shekels, L. L., Hunninghake, D. A., Tisdale, A. S., Gipson, I. K., Kieliszewski, M., Kozak, C. A., and Ho, S. B. (1998) Biochem. J. 330, 1301-1308 |
| 43. | Khatri, I., Fostner, G., and Fostner, J. (1997) Biochim. Biophys. Acta 1326, 7-11[Medline] [Order article via Infotrieve] |
| 44. |
Shogren, R. L.,
Jamieson, A. M.,
Blackwell, J.,
and Jentoft, N.
(1984)
J. Biol. Chem.
259,
14657-14662 |
| 45. | Strous, G. J., and Dekker, J. (1992) Crit. Rev. Biochem. Mol. Biol. 27, 57-92[Medline] [Order article via Infotrieve] |
| 46. | McCool, D. J., Forstner, G., and Forstner, J. (1994) Biochem. J. 302, 111-118 |
| 47. | Sheehan, J. K., Thornton, D. J., Howard, M., Carlstedt, I., Corfield, A. P., and Pareskeva, C. (1996) Biochem. J. 315, 1055-1060 |
| 48. |
Van Klinken, B. J.-W.,
Einerhand, A. W. C.,
Buller, H. A.,
and Dekker, J.
(1998)
Glycobiology
8,
67-75 |
| 49. |
Asker, N.,
Axelsson, M. A. B.,
Olofsson, S.-O.,
and Hansson, G. C.
(1998)
J. Biol. Chem.
273,
18857-18863 |
| 50. | Asker, N., Axelsson, M. A. B., Olofsson, S.-O., and Hansson, G. C. (1998) Biochem. J. 335, 381-387 |
| 51. | Perez-Vilar, J., and Hill, R. L. (1998) J. Biol. Chem. 273, 33527-33534 |
| 52. | Perez-Vilar, J., and Hill, R. L. (1999) in Sialobiology and Other Novel Forms of Glycosylation (Inoue, Y. , Lee, Y. C. , and Troy, F. A., II, eds) , Gakushin Publishing, Co., Suita, Osaka, Japan, in press |
| 53. |
Perez-Vilar, J.,
and Hill, R. L.
(1997)
J. Biol. Chem.
272,
33410-33415 |
| 54. |
Roth, J.,
Wang, Y.,
Eckhardt, A. E.,
and Hill, R. L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8935-8939 |
| 55. |
Deschuyteneer, M.,
Eckhardt, A. E.,
Roth, J.,
and Hill, R. L.
(1988)
J. Biol. Chem.
263,
2452-2459 |
| 56. |
Roth, J.
(1984)
J. Cell Biol.
98,
399-406 |
| 57. |
Perez-Vilar, J.,
Hidalgo, J.,
and Velasco, A.
(1991)
J. Biol. Chem.
266,
23967-23976 |
| 58. | Van Den Steen, P., Rudd, P. M., Dwek, R. A., and Opdenakker, G. (1998) Crit. Rev. Biochem. Mol. Biol. 33, 151-168[CrossRef][Medline] [Order article via Infotrieve] |
| 59. |
Herrmann, A.,
Davies, J. R.,
Lindell, G.,
Martensson, S.,
Packer, N. H.,
Swallow, D. M.,
and Carlstedt, I.
(1999)
J. Biol. Chem.
274,
15828-15836 |
| 60. | Wickstrom, C., Davies, J. R., Eriksen, G. V., Veerman, E. C. I., and Carlstedt, I. (1998) Biochem. J. 334, 685-693 |
| 61. | Gongqiao, X. G., Forstner, G. G., and Forstner, J. F. (1996) Glycoconjugate J. 13, 81-90[CrossRef][Medline] [Order article via Infotrieve] |
| 62. |
Eckhardt, A. E.,
Timpte, C. S.,
Abernethy, J. L.,
Zhao, Y.,
and Hill, R. L.
(1991)
J. Biol. Chem.
266,
9678-9686 |
| 63. | Khatri, I. A., Forstner, G. G., and Forstner, J. F. (1998) Biochem. J. 331, 323-330 |
| 64. | Sheehan, J. K., Howard, M., Richardson, P. S., Longwill, T., and Thornton, D. J. (1999) Biochem. J. 338, 507-513 |
| 65. |
Axelsson, M. A. B.,
Asker, N.,
and Hansson, G. C.
(1998)
J. Biol. Chem.
273,
18864-18870 |
| 66. |
Aksoy, N.,
Thornton, D. J.,
Corfield, A.,
Paraskeva, C.,
and Sheehan, J. K.
(1999)
Glycobiology
9,
739-746 |
| 67. | Hovenberg, H. W., Davies, J. R., and Carlstedt, I. (1996) Biochem. J. 318, 319-324 |
This article has been cited by other articles:
![]() |
K. Amano, Y. Chiba, Y. Kasahara, Y. Kato, M. K. Kaneko, A. Kuno, H. Ito, K. Kobayashi, J. Hirabayashi, Y. Jigami, et al. Engineering of mucin-type human glycoproteins in yeast cells PNAS, March 4, 2008; 105(9): 3232 - 3237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Brunelli, M. Papi, G. Arcovito, A. Bompiani, M. Castagnola, T. Parasassi, B. Sampaolese, F. Vincenzoni, and M. De Spirito Globular structure of human ovulatory cervical mucus FASEB J, December 1, 2007; 21(14): 3872 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lang, G. C. Hansson, and T. Samuelsson Gel-forming mucins appeared early in metazoan evolution PNAS, October 9, 2007; 104(41): 16209 - 16214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood, September 15, 2007; 110(6): 1723 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tan and P.-W. Cheng Mucin Biosynthesis: Identification of the cis-Regulatory Elements of Human C2GnT-M Gene Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 737 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. W. Smolenaars, O. Madsen, K. W. Rodenburg, and D. J. Van der Horst Molecular diversity and evolution of the large lipid transfer protein superfamily J. Lipid Res., March 1, 2007; 48(3): 489 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Perez-Vilar Mucin Granule Intraluminal Organization Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Russo, S. Spurr-Michaud, A. Tisdale, J. Pudney, D. Anderson, and I. K. Gipson Mucin gene expression in human male urogenital tract epithelia Hum. Reprod., November 1, 2006; 21(11): 2783 - 2793. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Buskas, S. Ingale, and G.-J. Boons Glycopeptides as versatile tools for glycobiology Glycobiology, August 1, 2006; 16(8): 113R - 136R. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Saegusa, T. Tanaka, S. Tani, S. Itohara, K. Mikoshiba, and M. Fukuda Decreased basal mucus secretion by Slp2-a-deficient gastric surface mucous cells Genes Cells, June 1, 2006; 11(6): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lievin-Le Moal and A. L. Servin The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota Clin. Microbiol. Rev., April 1, 2006; 19(2): 315 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Perez-Vilar, R. Mabolo, C. T. McVaugh, C. R. Bertozzi, and R. C. Boucher Mucin Granule Intraluminal Organization in Living Mucous/Goblet Cells: ROLES OF PROTEIN POST-TRANSLATIONAL MODIFICATIONS AND SECRETION J. Biol. Chem., February 24, 2006; 281(8): 4844 - 4855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Rhee, J. Marcelino, S. Al-Mayouf, D. K. Schelling, C. F. Bartels, Y. Cui, R. Laxer, R. Goldbach-Mansky, and M. L. Warman Consequences of Disease-causing Mutations on Lubricin Protein Synthesis, Secretion, and Post-translational Processing J. Biol. Chem., September 2, 2005; 280(35): 31325 - 31332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ercan and C. M. West Kinetic analysis of a Golgi UDP-GlcNAc:polypeptide-Thr/Ser N-acetyl-{alpha}-glucosaminyltransferase from Dictyostelium Glycobiology, May 1, 2005; 15(5): 489 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Perez-Vilar, J. C. Olsen, M. Chua, and R. C. Boucher pH-dependent Intraluminal Organization of Mucin Granules in Live Human Mucous/Goblet Cells J. Biol. Chem., April 29, 2005; 280(17): 16868 - 16881. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Olson, M. Backstrom, H. Karlsson, J. Burchell, and G. C. Hansson A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase Glycobiology, February 1, 2005; 15(2): 177 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Allen and G. Flemstrom Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin Am J Physiol Cell Physiol, January 1, 2005; 288(1): C1 - C19. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lang, M. Alexandersson, G. C. Hansson, and T. Samuelsson Bioinformatic identification of polymerizing and transmembrane mucins in the puffer fish Fugu rubripes Glycobiology, June 1, 2004; 14(6): 521 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Sheehan, S. Kirkham, M. Howard, P. Woodman, S. Kutay, C. Brazeau, J. Buckley, and D. J. Thornton Identification of Molecular Intermediates in the Assembly Pathway of the MUC5AC Mucin J. Biol. Chem., April 9, 2004; 279(15): 15698 - 15705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Perez-Vilar, S. H. Randell, and R. C. Boucher C-Mannosylation of MUC5AC and MUC5B Cys subdomains Glycobiology, April 1, 2004; 14(4): 325 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, T. Metcalf, H. van der Wel, and C. M. West Initiation of Mucin-type O-Glycosylation in Dictyostelium Is Homologous to the Corresponding Step in Animals and Is Important for Spore Coat Function J. Biol. Chem., December 19, 2003; 278(51): 51395 - 51407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lidell, M. E. V. Johansson, and G. C. Hansson An Autocatalytic Cleavage in the C Terminus of the Human MUC2 Mucin Occurs at the Low pH of the Late Secretory Pathway J. Biol. Chem., April 11, 2003; 278(16): 13944 - 13951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Gerken, J. Zhang, J. Levine, and A. Elhammer Mucin Core O-Glycosylation Is Modulated by Neighboring Residue Glycosylation Status. KINETIC MODELING OF THE SITE-SPECIFIC GLYCOSYLATION OF THE APO-PORCINE SUBMAXILLARY MUCIN TANDEM REPEAT BY UDP-GalNAc:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES T1 AND T2 J. Biol. Chem., December&nbs |